Recent advances in genome editing and creation of genetically modified pigs

International Journal of Surgery

Volumn 23, Issue , 2015, Pages 217-222

  Butler, James R ^a   Ladowski, Joseph M ^a   Martens, Gregory R ^a   Tector, Matthew ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endonuclease; Homologous recombination; Off target; TALEN CRISPR Cas9; Zinc finger nuclease

Indexed keywords

CRISPR ASSOCIATED PROTEIN; NUCLEASE; TALEN NUCLEASE; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE;

CELL NUCLEUS TRANSPLANTATION; GENE TARGETING; GENETIC ENGINEERING; GENOME EDITING; NONHUMAN; PIG; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; TRANSGENE; TRANSGENIC ANIMAL; XENOTRANSPLANTATION; ANIMAL; GENETICS; GENOME; PROCEDURES; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENETIC ENGINEERING; GENOME; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84951573938     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.07.684     Document Type: Review

References (48)

1. Capecchi M.R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. Genet. 2005, 6(6):507-512.
2. Lutz A.J., et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 2013, 20(1):27-35.
3. Estrada J.L., et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/beta4GalNT2 genes. Xenotransplantation 2015, 22(3):194-202.
4. Sandrin M.S., Osman N., McKenzie I.F. Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation. Front. Biosci. 1997, 2:e1-11.
5. Costa C., et al. Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J. 1999, 13(13):1762-1773.
6. Campbell K.H., et al. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996, 380(6569):64-66.
7. Lai L., et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002, 295(5557):1089-1092.
8. Polejaeva I.A., et al. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000, 407(6800):86-90.
9. Phelps C.J., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003, 299(5605):411-414.
10. Gaj T., Gersbach C.A., Barbas C.F. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013, 31(7):397-405.
11. Orlando S.J., et al. Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res. 2010, 38(15):e152.
12. Szczepek M., et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat. Biotechnol. 2007, 25(7):786-793.
13. Christian M., et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 2010, 186(2):757-761.
14. Carlson D.F., et al. Efficient TALEN-mediated gene knockout in livestock. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(43):17382-17387.
15. Xin J., et al. Highly efficient generation of GGTA1 biallelic knockout inbred mini-pigs with TALENs. PLoS One 2013, 8(12):e84250.
16. Wiedenheft B., Sternberg S.H., Doudna J.A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012, 482(7385):331-338.
17. Mali P., Esvelt K.M., Church G.M. Cas9 as a versatile tool for engineering biology. Nat. Methods 2013, 10(10):957-963.
18. Marraffini L.A., Sontheimer E.J. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 2010, 463(7280):568-571.
19. Jinek M., et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337(6096):816-821.
20. Li P., et al. Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection. Xenotransplantation 2015, 22(1):20-31.
21. Wood A.J., et al. Targeted genome editing across species using ZFNs and TALENs. Science 2011, 333(6040):307.
22. Fu Y., et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 2014, 32(3):279-284.
23. Ramirez C.L., et al. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res. 2012, 40(12):5560-5568.
24. Shen B., et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res. 2013, 23(5):720-723.
25. Ran F.A., et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154(6):1380-1389.
26. Zhang H., et al. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation. Plant Biotechnol. J. 2014, 12(6):797-807.
27. Veres A., et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell 2014, 15(1):27-30.
28. Fodor W.L., et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(23):11153-11157.
29. Cozzi E., White D.J. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1995, 1(9):964-966.
30. Osman N., et al. Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(26):14677-14682.
31. Diamond L.E., et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001, 71(1):132-142.
32. Miyagawa S., et al. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J. Biol. Chem. 2001, 276(42):39310-39319.
33. Klose R., et al. Expression of biologically active human trail in transgenic pigs. Transplantation 2005, 80(2):222-230.
34. Wu G., et al. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes. Xenotransplantation 2007, 14(1):34-47.
35. Dieckhoff B., et al. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 2008, 15(1):36-45.
36. Phelps C.J., et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 2009, 16(6):477-485.
37. Petersen B., et al. Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation 2009, 16(6):486-495.
38. Weiss E.H., et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009, 87(1):35-43.
39. Oropeza M., et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 2009, 16(6):522-534.
40. Yazaki S., et al. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor. Xenotransplantation 2009, 16(6):511-521.
41. Hara H., et al. Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs. Invest. Ophthalmol. Vis. Sci. 2011, 52(8):5278-5286.
42. Seol J.e.a. Production of transgenic cloned miniature pigs with membrane-bound human fas ligand (FasL) by somatic cell nuclear transfer. Nat. Proc. Prepub. Res. Prelim. Find. 2010, (accessed 14.06.15). http://precedings.nature.com/documents/4539/version/1.
43. Cho B., et al. Generation of soluble human tumor necrosis factor-alpha receptor 1-Fc transgenic pig. Transplantation 2011, 92(2):139-147.
44. Yeom H.J., et al. Generation and characterization of human heme oxygenase-1 transgenic pigs. PLoS One 2012, 7(10):e46646.
45. Wheeler D.G., et al. Transgenic swine: expression of human CD39 protects against myocardial injury. J. Mol. Cell Cardiol. 2012, 52(5):958-961.
46. Klymiuk N., et al. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 2012, 61(6):1527-1532.
47. Reyes L.M., et al. Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease. J. Immunol. 2014, 193(11):5751-5757.
48. Paris L.L., et al. Reduced human platelet uptake by pig livers deficient in the asialoglycoprotein receptor 1 protein. Xenotransplantation 2015, 22(3):203-210.